Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cha

Showing results (291-300 of 317) with videos related to

Pageof 32
Sort By:
BJU International|July 20, 2012
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomyMichael Rink, Jens Hansen, Eugene K Cha, et al.
World Journal of Urology|March 13, 2021
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancerDavid D'Andrea, Francesco Soria, Anne J Grotenhuis, et al.
Annals of Surgical Oncology|July 19, 2012
Risk of cancer-specific mortality following recurrence after radical nephroureterectomyMichael Rink, Daniel Sjoberg, Evi Comploj, et al.
The Journal of Urology|June 16, 2012
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinomaMichael Rink, Brian D Robinson, David A Green, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial CarcinomaFrançois Audenet, Sumit Isharwal, Eugene K Cha, et al.
World Journal of Urology|September 27, 2012
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinomaHarun Fajkovic, Eugene K Cha, Evanguelos Xylinas, et al.
World Journal of Urology|May 4, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thoughtJ Palou, F Pisano, R Sylvester, et al.
BJU International|September 4, 2012
Predictors of cancer-specific mortality after disease recurrence following radical cystectomyMichael Rink, Daniel J Lee, Matthew Kent, et al.
European Urology|May 15, 2012
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinomaEvanguelos Xylinas, Michael Rink, Eugene K Cha, et al.
European Urology|October 29, 2011
Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessmentShahrokh F Shariat, Behfar Ehdaie, Michael Rink, et al.
Pageof 32

Showing results (291-300 of 317) with videos related to

Sort By:
Pageof 32
BJU International|July 20, 2012
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomyMichael Rink, Jens Hansen, Eugene K Cha, et al.
World Journal of Urology|March 13, 2021
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancerDavid D'Andrea, Francesco Soria, Anne J Grotenhuis, et al.
Annals of Surgical Oncology|July 19, 2012
Risk of cancer-specific mortality following recurrence after radical nephroureterectomyMichael Rink, Daniel Sjoberg, Evi Comploj, et al.
The Journal of Urology|June 16, 2012
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinomaMichael Rink, Brian D Robinson, David A Green, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial CarcinomaFrançois Audenet, Sumit Isharwal, Eugene K Cha, et al.
World Journal of Urology|September 27, 2012
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinomaHarun Fajkovic, Eugene K Cha, Evanguelos Xylinas, et al.
World Journal of Urology|May 4, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thoughtJ Palou, F Pisano, R Sylvester, et al.
BJU International|September 4, 2012
Predictors of cancer-specific mortality after disease recurrence following radical cystectomyMichael Rink, Daniel J Lee, Matthew Kent, et al.
European Urology|May 15, 2012
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinomaEvanguelos Xylinas, Michael Rink, Eugene K Cha, et al.
European Urology|October 29, 2011
Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessmentShahrokh F Shariat, Behfar Ehdaie, Michael Rink, et al.
Pageof 32